Edition:
United States

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
4:00pm EDT
Change (% chg)

$0.01 (+0.93%)
Prev Close
$1.07
Open
$1.09
Day's High
$1.12
Day's Low
$1.08
Volume
5,980
Avg. Vol
31,019
52-wk High
$4.25
52-wk Low
$0.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.40 -0.142
Mar '18 0.40 -0.136
FY 2017 Dec '17 0.48 0.306
Sep '17 0.31 -0.117
Jun '17 1.00 -0.157
Mar '17 0.88 -0.171
FY 2016 Dec '16 0.91 -0.211
Sep '16 0.75 -0.292
Jun '16 1.13 -0.261
Mar '16 1.22 -0.258
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.45 0.90 0.00 --
Quarter Ending Dec-18 2 0.51 1.03 0.00 --
Year Ending Dec-18 2 1.75 2.70 0.80 4.10
Year Ending Dec-19 2 1.40 2.80 0.00 4.10
Earnings (per share)
Quarter Ending Sep-18 2 -0.14 -0.11 -0.16 --
Quarter Ending Dec-18 2 -0.14 -0.11 -0.18 --
Year Ending Dec-18 2 -0.57 -0.53 -0.62 -0.76
Year Ending Dec-19 2 -0.50 -0.47 -0.53 -0.76
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 13.25 98.72 30.39
P/E High - Last 5 Yrs. 17.41 271.03 47.38
P/E Low - Last 5 Yrs. 17.41 94.74 24.76
Beta -2.65 0.77 0.84
Price to Sales (TTM) 20.07 126.38 5.97
Price to Book (MRQ) 3.33 12.33 3.68
Price to Tangible Book (MRQ) 3.35 18.28 5.55
Price to Cash Flow (TTM) 16.69 59.02 20.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.46 -6.01
Payout Ratio(TTM) 0.00 6.12 46.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -59.46 160.40 7.40
Sales (TTM) vs TTM 1 Yr. Ago -54.88 92.02 6.42
Sales - 5 Yr. Growth Rate 7.03 24.32 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.45 75.74 23.76
EPS (TTM) vs TTM 1 Yr. Ago 89.22 -- --
EPS - 5 Yr. Growth Rate -- 23.18 7.50
Capital Spending - 5 Yr. Growth Rate -20.75 36.89 8.03

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.66 2.50
Current Ratio (MRQ) 10.26 5.35 3.53
LT Debt to Equity (MRQ) 35.06 17.95 11.23
Total Debt to Equity (MRQ) 35.06 20.97 14.17
Interest Coverage (TTM) -38.44 -189.65 31.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.07 55.31
Gross Margin - 5 Yr. Avg. -- 52.57 53.32
EBITD Margin (TTM) -855.33 -- --
EBITD - 5 Yr. Avg -314.28 -189.87 15.82
Operating Margin (TTM) 118.44 -674.65 3.86
Operating Margin - 5 Yr. Avg. -246.88 -203.27 10.94
Pre-Tax Margin (TTM) 111.42 -666.53 4.16
Pre-Tax Margin - 5 Yr. Avg. -253.78 -204.44 11.11
Net Profit Margin (TTM) 111.42 -656.77 0.97
Net Profit Margin - 5 Yr. Avg. -253.78 -202.01 7.46
Effective Tax Rate (TTM) -- 11.17 20.37
Effective Tax Rate - 5 Yr. Avg. -- 18.61 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,094,116 721,828,383
Net Income/Employee (TTM) -- -6,334,673 84,004,691
Receivable Turnover (TTM) 5.31 5.49 5.38
Inventory Turnover (TTM) -- 2.11 3.51
Asset Turnover (TTM) 0.11 0.38 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 12.44 0.13 10.03
Return on Assets - 5 Yr. Avg. -68.39 2.30 10.96
Return on Investment (TTM) 33.55 0.92 12.61
Return on Investment - 5 Yr. Avg. -100.87 1.68 14.17
Return on Equity (TTM) 116.61 -0.89 14.80
Return on Equity - 5 Yr. Avg. -- -7.01 15.53
  1 Year 3 Year 5 Year
Sales % -33.32 -17.72 7.03
EPS (TTM) % 108.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Capricor Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -15.75 -17.22 36 19
13 Week -22.46 -25.83 52 50
26 Week -42.16 -44.69 34 49
52 Week 0.00 -15.10 99 82
YTD -32.28 -36.63 49 76
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.89%
# of Holders: 22
Total Shares Held: 2,426,677
3 Mo. Net Change: 50,308
# New Positions: 3
# Closed Positions: 5
# Increased Positions: 9
# Reduced Positions: 6
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.